Kura Oncology (KURA) Treasury Shares (2014 - 2026)

Kura Oncology (KURA) posted quarterly Treasury Shares of $436667.0 for Q1 2026, little changed quarter-over-quarter from $436667.0 in Q4 2025.

Kura Oncology (KURA) Treasury Shares (2014 - 2026) Analysis & Trends

Kura Oncology (KURA) has reported Treasury Shares for 7 consecutive years, with $436667.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Treasury Shares changed N/A year-over-year to $436667.0; the TTM figure through Mar 2026 stood at $436667.0 (changed N/A YoY), while the FY2025 annual figure was $436667.0, changed N/A from the prior year.
Treasury Shares steadied at $436667.0 in Q1 2026 per KURA's latest filing, from $436667.0 in the prior quarter.
Across five years, Treasury Shares topped out at $775534.0 in Q3 2025 and bottomed at $436667.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Kura Oncology	966.11 Mn	966.11 Mn	20.63 Mn	-

Download Data